Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON WOCKHARDT BIOCON /
WOCKHARDT
 
P/E (TTM) x 19.7 -15.8 - View Chart
P/BV x 1.8 2.5 71.5% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 BIOCON    WOCKHARDT
EQUITY SHARE DATA
    BIOCON
Mar-23
WOCKHARDT
Mar-23
BIOCON /
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs388316 122.9%   
Low Rs192145 131.8%   
Sales per share (Unadj.) Rs93.1184.0 50.6%  
Earnings per share (Unadj.) Rs5.4-43.1 -12.4%  
Cash flow per share (Unadj.) Rs14.6-25.7 -57.0%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs146.5231.7 63.3%  
Shares outstanding (eoy) m1,200.60144.09 833.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.11.3 248.5%   
Avg P/E ratio x54.1-5.3 -1,011.7%  
P/CF ratio (eoy) x19.8-9.0 -220.7%  
Price / Book Value ratio x2.01.0 198.8%  
Dividend payout %28.00-   
Avg Mkt Cap Rs m347,81433,202 1,047.6%   
No. of employees `000NANA-   
Total wages/salary Rs m21,8106,370 342.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,74226,510 421.5%  
Other income Rs m7,6811,220 629.6%   
Total revenues Rs m119,42327,730 430.7%   
Gross profit Rs m16,611-1,930 -860.7%  
Depreciation Rs m11,1312,510 443.5%   
Interest Rs m4,1903,020 138.7%   
Profit before tax Rs m8,971-6,240 -143.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,541-30 -8,470.0%   
Profit after tax Rs m6,430-6,210 -103.5%  
Gross profit margin %14.9-7.3 -204.2%  
Effective tax rate %28.30.5 5,891.5%   
Net profit margin %5.8-23.4 -24.6%  
BALANCE SHEET DATA
Current assets Rs m123,34019,140 644.4%   
Current liabilities Rs m85,10734,350 247.8%   
Net working cap to sales %34.2-57.4 -59.6%  
Current ratio x1.40.6 260.1%  
Inventory Days Days12939 327.6%  
Debtors Days Days11711 1,063.6%  
Net fixed assets Rs m394,07848,670 809.7%   
Share capital Rs m6,003720 833.8%   
"Free" reserves Rs m169,92632,660 520.3%   
Net worth Rs m175,92933,380 527.0%   
Long term debt Rs m152,9052,240 6,826.1%   
Total assets Rs m517,41870,750 731.3%  
Interest coverage x3.1-1.1 -294.6%   
Debt to equity ratio x0.90.1 1,295.2%  
Sales to assets ratio x0.20.4 57.6%   
Return on assets %2.1-4.5 -45.5%  
Return on equity %3.7-18.6 -19.6%  
Return on capital %4.0-9.0 -44.3%  
Exports to sales %3.10-   
Imports to sales %6.03.5 171.6%   
Exports (fob) Rs m3,467NA-   
Imports (cif) Rs m6,654920 723.3%   
Fx inflow Rs m3,467730 474.9%   
Fx outflow Rs m6,654920 723.3%   
Net fx Rs m-3,187-190 1,677.4%   
CASH FLOW
From Operations Rs m18,5251,530 1,210.8%  
From Investments Rs m-142,818-1,250 11,425.4%  
From Financial Activity Rs m130,487-3,150 -4,142.4%  
Net Cashflow Rs m6,411-2,800 -229.0%  

Share Holding

Indian Promoters % 40.4 54.9 73.5%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 4.5 470.1%  
FIIs % 6.6 4.2 157.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 45.1 87.3%  
Shareholders   434,339 161,813 268.4%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Wockhardt Share Price Performance

Period Biocon Wockhardt S&P BSE HEALTHCARE
1-Day 2.88% 4.99% 1.35%
1-Month -2.57% 0.15% -0.59%
1-Year 30.47% 290.07% 62.09%
3-Year CAGR -13.56% 13.79% 18.22%
5-Year CAGR -2.73% 7.92% 19.83%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Biocon, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.